Interaction between warfarin and nafcillin: Case report and review of the literature

Pharmacotherapy

Volumn 27, Issue 10, 2007, Pages 1467-1470

  Kim, Karissa Y ^a   Frey, R J ^b   Epplen, Kelly ^b   Foruhari, Farzin ^b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b St Luke Hospitals Kentucky   (United States)

Author keywords

Drug interaction; Nafcillin; Warfarin

Indexed keywords

CEFAZOLIN; CIPROFLOXACIN; ENOXAPARIN; NAFCILLIN; OXYCODONE; PARACETAMOL; VANCOMYCIN; WARFARIN;

ADULT; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; ARTICLE; BACTERIAL ARTHRITIS; CASE REPORT; DEEP VEIN THROMBOSIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; PATIENT MONITORING;

ADULT; ANTI-BACTERIAL AGENTS; ANTICOAGULANTS; DRUG INTERACTIONS; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; NAFCILLIN; VENOUS THROMBOSIS; WARFARIN;

EID: 34948900908     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.27.10.1467     Document Type: Article

References (15)

1. Ansell J, Hirsh J, Poller L, et al. The pharmacology and management of the vitamin K antagonists: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126:204S-33.
2. Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions. Arch Int Med 2005;165:1095-106.
3. Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med 1994;121:676-83.
4. Greenblatt DJ, von Moltke LL. Interaction of warfarin with drugs, natural substances, and foods. J Clin Pharmacol 2005;45:127-32.
5. Qureshi GD, Reinders TP, Somori GJ, Evans HJ. Warfarin resistance with nafcillin therapy. Ann Intern Med 1984;100:527-9.
6. Davis RL, Berman W, Wernly JA, Kelly HW. Warfarin-nafcillin interaction. J Pediatr 1991;118:300-3.
7. Fraser GL, Miller M, Kane K. Warfarin resistance associated with nafcillin therapy. Am J Med 1989;87:237-8.
8. Heilker GM, Fowler JW, Self TH. Possible nafcillin-warfarin interaction. Arch Intern Med 1994;154:822-4.
9. Shovick VA, Rihn TL. Decreased hypoprothrombinemic response to warfarin secondary to the warfarin-nafcillin interaction. Ann Pharmacother 1991;25:598-9.
10. Taylor AT, Pritchard DC, Goldstein AO, Fletcher JL. Continuation of warfarin-nafcillin interaction during dicloxacillin therapy. J Fam Pract 1994;39:182-5.
11. Bristol Myers Squibb. Coumadin (warfarin) package insert. Princeton, NJ; 2006.
12. Cropp JS, Bussey HI. A review of enzyme induction of warfarin metabolism with recommendations for patient management. Pharmacotherapy 1997:17:917-28.
13. Janknegt R. The treatment of staphylococcal infections with special reference to pharmacokinetic, pharmacodynamic and pharmacoeconomic considerations. Pharm World Sci 1997;19:133-41.
14. Veremis SA, Maddux MS, Pollk R, Mozes MF. Subtherapeutic cyclosporin concentrations during nafcillin therapy. Transplantation 1987;43:913-15.
15. Lang CC, Jamal SK, Mohamed Z, Mustafa MR, Mustafa AM, Lee TC. Evidence of an interaction between nifedipine and nafcillin in humans. Br J Clin Pharmacol 2003;55:588-90.